Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
01 6Pharmathen SA
02 3Towa Pharmaceutical
03 2Mankind Pharma
04 6A. Menarini
05 2ANI Pharmaceuticals Inc
06 2ARTHUR GRP
07 5Accord healthcare
08 2Actavis Inc
09 6Adamed Pharma
10 2Ajanta Pharma Limited
11 2Alkem Laboratories
12 3Alter Laboratories Sa
13 2Amneal Pharmaceuticals
14 4Ascent Innovative Medicines
15 2Aurobindo Pharma Limited
16 2Cadila Pharmaceuticals
17 2Chartwell Pharmaceuticals llc
18 3Cinfa
19 2Cipla
20 3DOC Generici
21 3EG Spa
22 3ELC Group
23 2Glenmark Pharmaceuticals
24 3Grindeks AS
25 2Hetero Drugs
26 1Ind Swift Laboratories Limited
27 4Intas Pharmaceuticals
28 3Intas Third Party Sales 2005 Sl
29 2Jubilant Generics
30 2KYE Pharmaceuticals
31 9Krka
32 3LABORATORIOS NORMON SA
33 2MENARINI INTL
34 25Menarini
35 3Menarini South Africa (Pty) Ltd
36 2Micro Labs Limited
37 2Novast Laboratories
38 1Pantson Pharma Pvt. Limited
39 2Piramal Pharma Solutions
40 1Ravenbhel Pharma
41 2Rising Pharmaceuticals Inc
42 2SCIEGEN PHARMS
43 6STADA Arzneimittel
44 3Sandoz B2B
45 2Spil
46 2Sun Pharmaceutical Industries Limited
47 2Sunshine Lake Pharma
48 5Teva Pharmaceutical Industries
49 2Torrent Pharmaceuticals Limited
50 3Umedica Laboratories
51 5Unichem Laboratories Limited
52 2Unichem Pharmaceuticals USA, Inc
53 2VKT Pharma
54 1Vega Biotech Pvt. Ltd.
55 2i3 Pharmaceuticals
01 5ER Tablet
02 1EXTENDED RELEASETABLET
03 3Extended Release Tablet
04 12Extended Release Tablets
05 46Extended-Release Tablet
06 2GRANULES, EXTENDED RELEASE;ORAL
07 3Modified Release Tablet
08 3Prolonged Release Tablet
09 3Prolonged Release Tablets
10 3Prolonged-Release Tablet
11 1Ranolazina 375Mg 60 Units Oral Use Rp
12 1Ranolazina 500Mg 60 Units Oral Use Rp
13 1Ranolazina 750Mg 60 Units Oral Use Rp
14 3SRT
15 1TABLET
16 2TABLET (EXTENDED-RELEASE)
17 56TABLET, EXTENDED RELEASE;ORAL
18 27Tablet
19 4XR Tablet
01 3Allowed
02 3Approved
03 44Authorized
04 18DISCN
05 7Generic
06 3Originator
07 20Prescription
08 38RX
09 3Suspended
10 38Blank
01 2ASPRUZYO SPRINKLE
02 2CORZYNA
03 3Halibrell
04 3Labigat
05 1Nefazor
06 5RANEXA
07 3RANOLAZINA DOC GENERIC
08 3RANOLAZINA EG
09 3RANOLAZINA KRKA
10 54RANOLAZINE
11 3RANOZEK
12 1Ranazine 500 SR
13 26Ranexa
14 1Ranexa 375 mg
15 1Ranexa 500 mg
16 1Ranexa 750 mg
17 1Ranexa® 1000
18 1Ranexa® 500
19 3Ranolazina Alter
20 3Ranolazina Cinfa
21 3Ranolazina Intas
22 3Ranolazina Krka
23 3Ranolazina Normon
24 3Ranolazina Stada
25 3Ranolazina Umedica
26 3Ranolazine Accord
27 3Ranolazine Elc
28 3Ranolazine Stada
29 3Ranolazine Teva
30 3Ranolazine Thinks
31 3Ranozek
32 3Tezulix
33 21Blank
01 2Canada
02 18Estonia
03 3Greece
04 17India
05 18Italy
06 3Latvia
07 2Moldova
08 3South Africa
09 47Spain
10 3Sweden
11 3Switzerland
12 58USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 375MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ranolazine Thinks
Dosage Form : Extended-Release Tablet
Dosage Strength : 500MG
Packaging :
Approval Date : 06-02-2024
Application Number : 89168
Regulatory Info : Authorized
Registration Country : Spain
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2020-02-12
Application Number : 212284
Regulatory Info : RX
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 750MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Labigat
Dosage Form : Prolonged Release Tablets
Dosage Strength : 500MG
Packaging :
Approval Date : 28-07-2025
Application Number : 90472
Regulatory Info : Authorized
Registration Country : Spain
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Labigat
Dosage Form : Prolonged Release Tablets
Dosage Strength : 375MG
Packaging :
Approval Date : 28-07-2025
Application Number : 90471
Regulatory Info : Authorized
Registration Country : Spain
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Labigat
Dosage Form : Prolonged Release Tablets
Dosage Strength : 750MG
Packaging :
Approval Date : 28-07-2025
Application Number : 90473
Regulatory Info : Authorized
Registration Country : Spain
Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ranolazine Thinks
Dosage Form : Extended-Release Tablet
Dosage Strength : 375MG
Packaging :
Approval Date : 06-02-2024
Application Number : 89167
Regulatory Info : Authorized
Registration Country : Spain
Towa Pharma is dedicated to researching, developing, producing, and promoting generic drugs.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Ranolazine Thinks
Dosage Form : Extended-Release Tablet
Dosage Strength : 750MG
Packaging :
Approval Date : 06-02-2024
Application Number : 89169
Regulatory Info : Authorized
Registration Country : Spain
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2020-02-12
Application Number : 212284
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2019-05-28
Application Number : 208862
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2021-03-11
Application Number : 207690
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2021-03-11
Application Number : 207690
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date : 2013-07-29
Application Number : 201046
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2013-07-29
Application Number : 201046
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number : 208174
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : RANOLAZINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1000MG
Packaging :
Approval Date :
Application Number : 208174
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANEXA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2007-02-12
Application Number : 21526
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : RANEXA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2006-01-27
Application Number : 21526
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
